J 2021

Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis

PAZDERNIK, Michal, Helena BEDANOVA, Zhi CHEN, Josef KAUTZNER, Vojtech MELENOVSKY et. al.

Základní údaje

Originální název

Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis

Autoři

PAZDERNIK, Michal (203 Česká republika, garant), Helena BEDANOVA (203 Česká republika), Zhi CHEN, Josef KAUTZNER (203 Česká republika), Vojtech MELENOVSKY (203 Česká republika), Ivan MALEK (203 Česká republika), Antonij SLAVCEV, Michaela BARTONOVA (203 Česká republika), Vladimir KARMAZIN (203 Česká republika), Tomas ECKHARDT (203 Česká republika), Ales TOMASEK (203 Česká republika), Eva OZÁBALOVÁ (203 Česká republika, domácí), Tomas KOVARNIK (203 Česká republika), Peter WOHLFAHRT (203 Česká republika) a Milan SONKA (203 Česká republika)

Vydání

Transplant Immunology, Amsterdam, ELSEVIER, 2021, 0966-3274

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30213 Transplantation

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.032

Kód RIV

RIV/00216224:14110/21:00122148

Organizační jednotka

Lékařská fakulta

UT WoS

000633033800006

Klíčová slova anglicky

Cardiac allograft vasculopathy; Donor specific antibodies; Heart transplant; Intimal thickness

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 24. 8. 2021 08:58, Mgr. Tereza Miškechová

Anotace

V originále

Introduction: Recent studies suggested potential positive correlations between HLA-specific antibodies and development of cardiac allograft vasculopathy (CAV). Methods: This prospective two-center study investigated early progression of CAV by coronary optical coherence tomography in 1 month and 12 months after heart transplantation (HTx) in 104 patients. Detection and characterization of donor specific (DSA) and MHC class-I polypeptide-related sequence A (MICA) antibodies were performed before, 1, 6 and 12 months after transplantation. Results: During the first post-HTx year, we observed a significant reduction in the mean coronary luminal area (P < .001), and progression in mean intimal thickness (IT) (P < .001). DSA and anti-MICA occurred in 17% of all patients, but no significant relationship was observed between presence of DSA/anti-MICA and IT progression within 12 months after HTx. In contrast, we observed significant association between presence of DSA (p=0.031), de-novo DSA (p=0.031), HLA Class II DSA (p=0.017) and media thickness (MT) progression. Conclusion: Results of our study did not identify a direct association between presence of DSA/anti-MICA and intimal thickness progression in an early period after HTx. However, we found significant relationships between DSA and media thickness progression that may identify a newly recognized immune-pathological aspect of CAV.